✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Rhythm Pharmaceuticals, Inc.

Common Name
Rhythm Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
414
Ticker
RYTM
Exchange
Nasdaq
Description
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for rare neuroendocrine diseases. The company’s lead product, IMCIVREE ...

Rhythm Pharmaceuticals's Revenues Data

Explore Rhythm Pharmaceuticals's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
189,757,000a
130,126,000a
77,428,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Rhythm Pharmaceuticals’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Rhythm Pharmaceuticals's Annual Report 2025